Advertisement
Journal of Clinical Oncology  
Search for:
Limit by:
  Browse by Subject or Issue
Home Search or Browse JCO My JCO Subscriptions Customer Service Site Map

This Article
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a colleague
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Save to my personal folders
Right arrow Download to citation manager
Right arrowRights & Permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Solti, M.
Right arrow Articles by Abraksia, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Solti, M.
Right arrow Articles by Abraksia, S.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Facebook   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?
Journal of Clinical Oncology, Vol 19, Issue 19 (October), 2001: 3991-3993
© 2001 American Society for Clinical Oncology


DIAGNOSIS IN ONCOLOGY

Unusual Sites of Involvement by Hematologic Malignancies

Case 2. Meningeal Mycloma With Cord Compression

Magdolna Solti, P. Dileep Kumar, Samir Abraksia

Huron Hospital and Cancer Center, South Pointe Hospital, Cleveland Clinic Health System, Cleveland, OH

A 55-year-old woman presented with pathologic rib fractures, multiple osteolytic lesions, and anemia (hemoglobin level, 5.5 g/dL). She had hypergammaglobulinemia (5.4 g/dL), normal calcium level, and normal renal function. Serum protein electrophoresis revealed a monoclonal spike of gamma globulin. Serum immunofixation identified an immunoglobulin (Ig) G lambda-type M protein. A quantitative Ig assay showed an increase in the IgG level (3.54 g/dL), with diminished IgA and IgM levels. Urine immunofixation electrophoresis revealed Bence-Jones proteinuria (lambda light chain). Bone marrow biopsy showed an increased amount of plasma cells with mitotic features and pleomorphism. Multiple myeloma was diagnosed, and the patient was treated with RBC transfusions, dexamethasone, and pain medications. Three months later, the patient presented with midback pain, progressive bilateral leg weakness, and urinary retention. A neurologic examination revealed weakness of both the upper and lower extremities, bilaterally diminished ankle jerks, impaired fine touch, vibratory and position sensations in both legs, and unresponsive plantar reflexes.

A computed tomographic scan of the head showed lytic bone lesions in the calvarium but no intracranial abnormality. A magnetic resonance imaging scan of the cervical, thoracic, and lumbar spine showed an intradural but extramedullary soft tissue mass posterior and lateral to the spinal cord, which was enhanced with gadolinium contrast. The mass extended from the C2 to the S1 level (Fig 1, A and B). Treatment with melphalan and prednisone was started. An upper thoracic laminectomy performed at the T4 level revealed an epidural, friable gray mass constricting the spinal cord posteriorly. A histologic examination showed typical plasma cells with a few binucleated and mitotic forms (Fig 2).



View larger version (88K):
[in this window]
[in a new window]
 
Fig 1.

 


View larger version (120K):
[in this window]
[in a new window]
 
Fig 2.

 
The patient’s clinical status deteriorated rapidly. Her leg weakness progressed to paraplegia. On the third postoperative day she became stuporous and suddenly developed cardiorespiratory arrest necessitating intubation. Two days later the family opted to withdraw all life support measures and she died. An autopsy was not performed.

Meningeal involvement is a rare complication of multiple myeloma.1 The true incidence is unknown since only 41 cases have been reported in the English literature, the majority of which were localized to intracranial meninges or presented as disseminated disease.1-7 Meningeal spread can occur either by local invasion from the bone or by hematogenous dissemination.2-4 The natural history of meningeal myeloma is aggressive, characterized by rapid progression and resistance to therapy.4-7 Petersen et al7 reported a median survival of 1.5 months from the time of diagnosis of meningeal involvement. The therapeutic options are decompressive surgery and/or radiotherapy. Our patient is the fourth reported case of extensive spinal myeloma with cord compression. Meningeal involvement should be considered in myeloma patients who present with progressive paraplegia.

REFERENCES

1. Maldonado JE, Kyle RA, Ludwig J, et al: Meningeal myeloma. Arch Intern Med 126: 660-663, 1970[Abstract/Free Full Text]

2. Slager UT, Taylor WF, Opfell RW, et al: Leptomeningeal myeloma. Arch Pathol Lab Med 103: 680-682, 1979[Medline]

3. Quint DJ, Levy R, Krauss JC: MR of myelomatous meningitis. Am J Neuroradiol 16: 1316-1317, 1994[Abstract]

4. Shalay KM, Parikh JR: Meningeal myelomatosis. Can Assoc Radiol J 45: 460-462, 1994[Medline]

5. Mäntylä R, Kinnunen J, Böhling T: Intracranial plasmocytoma: A case report. Neuroradiology 38: 646-649, 1996[Medline]

6. Lolin YI, Lam CW, Lo WH, et al: IgD multiple myeloma with thoracic spine compression due to epidural extra-osseous tumour spread. J Clin Pathol 47: 669-671, 1994[Abstract/Free Full Text]

7. Petersen SL, Wagner A, Gimsing P: Cerebral and meningeal multiple myeloma after autologous stem cell transplantation: A case report and review of the literature. Am J Hematol 62: 228-233, 1999[Medline]


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Facebook Facebook   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?



This Article
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a colleague
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Save to my personal folders
Right arrow Download to citation manager
Right arrowRights & Permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Solti, M.
Right arrow Articles by Abraksia, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Solti, M.
Right arrow Articles by Abraksia, S.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Facebook   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

About
JCO
 Editorial
Roster
 Advertising
Information
 Librarians &
Institutions
 Rights &
Permissions
 PDA Services

Copyright © 2001 by the American Society of Clinical Oncology, Online ISSN: 1527-7755. Print ISSN: 0732-183X
Terms and Conditions of Use
  HighWire Press HighWire Press™ assists in the publication of JCO Online